About Revision Bio
Revision Bio is a Healthcare company based in Allston (United States) founded in 2023. It develops novel DNA Polymerase and Ligase-based systems for genome editing. It operates on a B2B model. Revision Bio offers products and services including 3D Editing and Ligase Editing. Its focus areas include Life Sciences, Biotechnology, Genome Editing and Gene Editing Technologies. Similar companies include Beam Therapeutics, eGenesis and Korro Bio; 3 of its 3 listed similar companies have raised funding.
Company details
Revision Bio focuses on creating innovative gene editing technologies, including 3D Editing and Ligase Editing, to enhance genetic medicine development. These systems improve processivity, fidelity, and versatility for DNA edits like insertions and deletions. Based in Allston, MA, the company emphasizes partnerships to advance therapeutic opportunities through proprietary tools.
- Headquarters Allston, United States
- SectorsHealthcare
- Email••••••••
- Website revision.bio
- Social Facebook
Products & Services of Revision Bio
Revision Bio offers a comprehensive portfolio of products and services, including 3D Editing and Ligase Editing.
Pairs DNA-binding protein with DNA Polymerase for precise genome modifications.
Uses DNA-binding protein and DNA Ligase for efficient DNA edits.
Similar companies to Revision Bio
Revision Bio has 3 listed similar companies in our database, 3 of them funded. They include Beam Therapeutics, eGenesis and Korro Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beamtx.com | 2017 | Cambridge, United States | $222M | 340 | Developer of gene therapy using CRISPR base editing to treat diseases | |
| egenesisbio.com | 2015 | Cambridge, United States | $481.42M | 94 | Gene transplantation platform for humanizing pig cells is developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed similar companies of Revision Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Revision Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Revision Bio
Revision Bio was founded in 2023.
Revision Bio is headquartered in Allston, United States. It is registered at Allston, Massachusetts, United States.
Revision Bio focuses on creating innovative gene editing technologies, including 3D Editing and Ligase Editing, to enhance genetic medicine development. These systems improve processivity, fidelity, and versatility for DNA edits like insertions and deletions. Based in Allston, MA, the company emphasizes partnerships to advance therapeutic opportunities through proprietary tools.
Revision Bio's top competitors include eGenesis, Korro Bio and Beam Therapeutics.
Revision Bio offers 3D Editing and Ligase Editing.